nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP3A4—Thiotepa—sarcoma	0.109	0.458	CbGbCtD
Esomeprazole—CYP3A4—Mitoxantrone—sarcoma	0.0467	0.197	CbGbCtD
Esomeprazole—CYP3A4—Vincristine—sarcoma	0.0321	0.136	CbGbCtD
Esomeprazole—CYP3A4—Etoposide—sarcoma	0.0295	0.124	CbGbCtD
Esomeprazole—ATP4A—larynx—sarcoma	0.0268	0.5	CbGeAlD
Esomeprazole—CYP3A4—Doxorubicin—sarcoma	0.0201	0.0847	CbGbCtD
Esomeprazole—ATP4B—liver—sarcoma	0.00631	0.117	CbGeAlD
Esomeprazole—ATP4A—hematopoietic system—sarcoma	0.0053	0.0987	CbGeAlD
Esomeprazole—ATP4A—connective tissue—sarcoma	0.0051	0.095	CbGeAlD
Esomeprazole—ATP4A—testis—sarcoma	0.0029	0.0541	CbGeAlD
Esomeprazole—ATP4A—liver—sarcoma	0.00274	0.0511	CbGeAlD
Esomeprazole—CYP2C19—hematopoietic system—sarcoma	0.00185	0.0345	CbGeAlD
Esomeprazole—CYP3A4—hematopoietic system—sarcoma	0.00109	0.0204	CbGeAlD
Esomeprazole—CYP2C19—liver—sarcoma	0.000959	0.0179	CbGeAlD
Esomeprazole—Upper respiratory tract infection—Epirubicin—sarcoma	0.000576	0.000812	CcSEcCtD
Esomeprazole—Asthma—Doxorubicin—sarcoma	0.000573	0.000809	CcSEcCtD
Esomeprazole—Influenza—Doxorubicin—sarcoma	0.000573	0.000809	CcSEcCtD
Esomeprazole—Dysphagia—Doxorubicin—sarcoma	0.000573	0.000809	CcSEcCtD
Esomeprazole—Pollakiuria—Epirubicin—sarcoma	0.000573	0.000807	CcSEcCtD
Esomeprazole—Hypersensitivity—Vincristine—sarcoma	0.000572	0.000806	CcSEcCtD
Esomeprazole—CYP3A4—liver—sarcoma	0.000567	0.0106	CbGeAlD
Esomeprazole—Photosensitivity reaction—Epirubicin—sarcoma	0.000566	0.000798	CcSEcCtD
Esomeprazole—Paraesthesia—Etoposide—sarcoma	0.000565	0.000796	CcSEcCtD
Esomeprazole—Weight increased—Epirubicin—sarcoma	0.000564	0.000795	CcSEcCtD
Esomeprazole—Pancreatitis—Doxorubicin—sarcoma	0.000562	0.000793	CcSEcCtD
Esomeprazole—Weight decreased—Epirubicin—sarcoma	0.000561	0.000791	CcSEcCtD
Esomeprazole—Dyspnoea—Etoposide—sarcoma	0.000561	0.00079	CcSEcCtD
Esomeprazole—Somnolence—Etoposide—sarcoma	0.000559	0.000788	CcSEcCtD
Esomeprazole—Angina pectoris—Doxorubicin—sarcoma	0.000559	0.000788	CcSEcCtD
Esomeprazole—Hypersensitivity—Mitoxantrone—sarcoma	0.000557	0.000785	CcSEcCtD
Esomeprazole—Asthenia—Vincristine—sarcoma	0.000557	0.000785	CcSEcCtD
Esomeprazole—Vomiting—Thiotepa—sarcoma	0.000557	0.000785	CcSEcCtD
Esomeprazole—Infestation NOS—Epirubicin—sarcoma	0.000553	0.000779	CcSEcCtD
Esomeprazole—Infestation—Epirubicin—sarcoma	0.000553	0.000779	CcSEcCtD
Esomeprazole—Vomiting—Dactinomycin—sarcoma	0.000552	0.000779	CcSEcCtD
Esomeprazole—Rash—Thiotepa—sarcoma	0.000552	0.000778	CcSEcCtD
Esomeprazole—Dermatitis—Thiotepa—sarcoma	0.000551	0.000777	CcSEcCtD
Esomeprazole—Headache—Thiotepa—sarcoma	0.000548	0.000773	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000548	0.000772	CcSEcCtD
Esomeprazole—Rash—Dactinomycin—sarcoma	0.000548	0.000772	CcSEcCtD
Esomeprazole—Decreased appetite—Etoposide—sarcoma	0.000547	0.000771	CcSEcCtD
Esomeprazole—Pancytopenia—Doxorubicin—sarcoma	0.000545	0.000768	CcSEcCtD
Esomeprazole—Renal failure—Epirubicin—sarcoma	0.000543	0.000766	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Etoposide—sarcoma	0.000543	0.000765	CcSEcCtD
Esomeprazole—Asthenia—Mitoxantrone—sarcoma	0.000542	0.000765	CcSEcCtD
Esomeprazole—Fatigue—Etoposide—sarcoma	0.000542	0.000764	CcSEcCtD
Esomeprazole—Jaundice—Epirubicin—sarcoma	0.000539	0.000759	CcSEcCtD
Esomeprazole—Stomatitis—Epirubicin—sarcoma	0.000539	0.000759	CcSEcCtD
Esomeprazole—Pain—Etoposide—sarcoma	0.000538	0.000758	CcSEcCtD
Esomeprazole—Constipation—Etoposide—sarcoma	0.000538	0.000758	CcSEcCtD
Esomeprazole—Conjunctivitis—Epirubicin—sarcoma	0.000537	0.000757	CcSEcCtD
Esomeprazole—Urinary tract infection—Epirubicin—sarcoma	0.000537	0.000757	CcSEcCtD
Esomeprazole—Dysuria—Doxorubicin—sarcoma	0.000536	0.000756	CcSEcCtD
Esomeprazole—Neutropenia—Doxorubicin—sarcoma	0.000536	0.000756	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000533	0.000751	CcSEcCtD
Esomeprazole—Diarrhoea—Vincristine—sarcoma	0.000531	0.000749	CcSEcCtD
Esomeprazole—Pollakiuria—Doxorubicin—sarcoma	0.00053	0.000747	CcSEcCtD
Esomeprazole—Haematuria—Epirubicin—sarcoma	0.000527	0.000743	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Doxorubicin—sarcoma	0.000523	0.000738	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Epirubicin—sarcoma	0.000523	0.000737	CcSEcCtD
Esomeprazole—Weight increased—Doxorubicin—sarcoma	0.000522	0.000736	CcSEcCtD
Esomeprazole—Epistaxis—Epirubicin—sarcoma	0.000521	0.000735	CcSEcCtD
Esomeprazole—Nausea—Thiotepa—sarcoma	0.00052	0.000733	CcSEcCtD
Esomeprazole—Weight decreased—Doxorubicin—sarcoma	0.000519	0.000731	CcSEcCtD
Esomeprazole—Sinusitis—Epirubicin—sarcoma	0.000518	0.000731	CcSEcCtD
Esomeprazole—Feeling abnormal—Etoposide—sarcoma	0.000518	0.00073	CcSEcCtD
Esomeprazole—Diarrhoea—Mitoxantrone—sarcoma	0.000517	0.000729	CcSEcCtD
Esomeprazole—Nausea—Dactinomycin—sarcoma	0.000516	0.000728	CcSEcCtD
Esomeprazole—Agranulocytosis—Epirubicin—sarcoma	0.000516	0.000727	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Etoposide—sarcoma	0.000514	0.000725	CcSEcCtD
Esomeprazole—Dizziness—Vincristine—sarcoma	0.000513	0.000724	CcSEcCtD
Esomeprazole—Infestation NOS—Doxorubicin—sarcoma	0.000511	0.000721	CcSEcCtD
Esomeprazole—Infestation—Doxorubicin—sarcoma	0.000511	0.000721	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000507	0.000715	CcSEcCtD
Esomeprazole—Bradycardia—Epirubicin—sarcoma	0.000505	0.000712	CcSEcCtD
Esomeprazole—Renal failure—Doxorubicin—sarcoma	0.000503	0.000709	CcSEcCtD
Esomeprazole—Urticaria—Etoposide—sarcoma	0.0005	0.000704	CcSEcCtD
Esomeprazole—Stomatitis—Doxorubicin—sarcoma	0.000498	0.000703	CcSEcCtD
Esomeprazole—Jaundice—Doxorubicin—sarcoma	0.000498	0.000703	CcSEcCtD
Esomeprazole—Rhinitis—Epirubicin—sarcoma	0.000497	0.000701	CcSEcCtD
Esomeprazole—Abdominal pain—Etoposide—sarcoma	0.000497	0.000701	CcSEcCtD
Esomeprazole—Body temperature increased—Etoposide—sarcoma	0.000497	0.000701	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—sarcoma	0.000497	0.000701	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—sarcoma	0.000497	0.000701	CcSEcCtD
Esomeprazole—Hepatitis—Epirubicin—sarcoma	0.000496	0.000699	CcSEcCtD
Esomeprazole—Hypoaesthesia—Epirubicin—sarcoma	0.000494	0.000696	CcSEcCtD
Esomeprazole—Vomiting—Vincristine—sarcoma	0.000494	0.000696	CcSEcCtD
Esomeprazole—Pharyngitis—Epirubicin—sarcoma	0.000492	0.000694	CcSEcCtD
Esomeprazole—Urinary tract disorder—Epirubicin—sarcoma	0.00049	0.000691	CcSEcCtD
Esomeprazole—Rash—Vincristine—sarcoma	0.000489	0.00069	CcSEcCtD
Esomeprazole—Dermatitis—Vincristine—sarcoma	0.000489	0.000689	CcSEcCtD
Esomeprazole—Oedema peripheral—Epirubicin—sarcoma	0.000489	0.000689	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—sarcoma	0.000488	0.000687	CcSEcCtD
Esomeprazole—Connective tissue disorder—Epirubicin—sarcoma	0.000488	0.000687	CcSEcCtD
Esomeprazole—Urethral disorder—Epirubicin—sarcoma	0.000486	0.000686	CcSEcCtD
Esomeprazole—Headache—Vincristine—sarcoma	0.000486	0.000686	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—sarcoma	0.000484	0.000682	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—sarcoma	0.000482	0.00068	CcSEcCtD
Esomeprazole—Vomiting—Mitoxantrone—sarcoma	0.000481	0.000678	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—sarcoma	0.00048	0.000676	CcSEcCtD
Esomeprazole—Visual impairment—Epirubicin—sarcoma	0.000478	0.000674	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—sarcoma	0.000477	0.000673	CcSEcCtD
Esomeprazole—Rash—Mitoxantrone—sarcoma	0.000477	0.000672	CcSEcCtD
Esomeprazole—Dermatitis—Mitoxantrone—sarcoma	0.000476	0.000671	CcSEcCtD
Esomeprazole—Headache—Mitoxantrone—sarcoma	0.000474	0.000668	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—sarcoma	0.000469	0.000661	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—sarcoma	0.000467	0.000659	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—sarcoma	0.000464	0.000654	CcSEcCtD
Esomeprazole—Hypersensitivity—Etoposide—sarcoma	0.000463	0.000653	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—sarcoma	0.000463	0.000652	CcSEcCtD
Esomeprazole—Nausea—Vincristine—sarcoma	0.000461	0.00065	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—sarcoma	0.00046	0.000649	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—sarcoma	0.00046	0.000649	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—sarcoma	0.000459	0.000647	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—sarcoma	0.000457	0.000644	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—sarcoma	0.000456	0.000642	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—sarcoma	0.000453	0.000639	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—sarcoma	0.000452	0.000638	CcSEcCtD
Esomeprazole—Asthenia—Etoposide—sarcoma	0.000451	0.000636	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—sarcoma	0.000451	0.000636	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—sarcoma	0.00045	0.000634	CcSEcCtD
Esomeprazole—Nausea—Mitoxantrone—sarcoma	0.000449	0.000633	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—sarcoma	0.000448	0.000632	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—sarcoma	0.000447	0.00063	CcSEcCtD
Esomeprazole—Chills—Epirubicin—sarcoma	0.000445	0.000628	CcSEcCtD
Esomeprazole—Pruritus—Etoposide—sarcoma	0.000445	0.000627	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—sarcoma	0.000442	0.000624	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—sarcoma	0.000438	0.000618	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—sarcoma	0.000435	0.000613	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—sarcoma	0.000434	0.000612	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—sarcoma	0.000432	0.000609	CcSEcCtD
Esomeprazole—Diarrhoea—Etoposide—sarcoma	0.00043	0.000607	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—sarcoma	0.000429	0.000605	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—sarcoma	0.000428	0.000603	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—sarcoma	0.000426	0.000601	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—sarcoma	0.000426	0.0006	CcSEcCtD
Esomeprazole—Tension—Epirubicin—sarcoma	0.000424	0.000597	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—sarcoma	0.000423	0.000596	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—sarcoma	0.000419	0.000591	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—sarcoma	0.000418	0.000589	CcSEcCtD
Esomeprazole—Dizziness—Etoposide—sarcoma	0.000416	0.000586	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—sarcoma	0.000415	0.000585	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—sarcoma	0.000415	0.000585	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—sarcoma	0.000414	0.000583	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—sarcoma	0.000412	0.000581	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—sarcoma	0.000407	0.000574	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—sarcoma	0.000406	0.000572	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—sarcoma	0.000402	0.000567	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—sarcoma	0.000401	0.000565	CcSEcCtD
Esomeprazole—Vomiting—Etoposide—sarcoma	0.0004	0.000564	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—sarcoma	0.0004	0.000563	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—sarcoma	0.000399	0.000563	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—sarcoma	0.000397	0.00056	CcSEcCtD
Esomeprazole—Rash—Etoposide—sarcoma	0.000396	0.000559	CcSEcCtD
Esomeprazole—Dermatitis—Etoposide—sarcoma	0.000396	0.000558	CcSEcCtD
Esomeprazole—Headache—Etoposide—sarcoma	0.000394	0.000555	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—sarcoma	0.000394	0.000555	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—sarcoma	0.000392	0.000553	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—sarcoma	0.000391	0.000552	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—sarcoma	0.000389	0.000549	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—sarcoma	0.000388	0.000547	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—sarcoma	0.000388	0.000547	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—sarcoma	0.000387	0.000545	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—sarcoma	0.000387	0.000545	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—sarcoma	0.000384	0.000542	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—sarcoma	0.000382	0.000538	CcSEcCtD
Esomeprazole—Cough—Epirubicin—sarcoma	0.000377	0.000531	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—sarcoma	0.000377	0.000531	CcSEcCtD
Esomeprazole—Nausea—Etoposide—sarcoma	0.000373	0.000527	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—sarcoma	0.000373	0.000526	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—sarcoma	0.000371	0.000523	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—sarcoma	0.000369	0.000521	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—sarcoma	0.000368	0.000518	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—sarcoma	0.000368	0.000518	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—sarcoma	0.000368	0.000518	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—sarcoma	0.000367	0.000518	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—sarcoma	0.000366	0.000517	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000365	0.000515	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—sarcoma	0.000363	0.000512	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—sarcoma	0.00036	0.000508	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—sarcoma	0.00036	0.000507	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—sarcoma	0.000359	0.000506	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—sarcoma	0.000358	0.000504	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—sarcoma	0.000355	0.000501	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—sarcoma	0.000353	0.000498	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—sarcoma	0.000352	0.000497	CcSEcCtD
Esomeprazole—Infection—Epirubicin—sarcoma	0.00035	0.000494	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—sarcoma	0.000349	0.000492	CcSEcCtD
Esomeprazole—Shock—Epirubicin—sarcoma	0.000347	0.000489	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—sarcoma	0.000346	0.000487	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—sarcoma	0.000345	0.000487	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—sarcoma	0.000345	0.000486	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—sarcoma	0.000344	0.000485	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—sarcoma	0.000342	0.000483	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—sarcoma	0.000341	0.00048	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—sarcoma	0.00034	0.00048	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—sarcoma	0.00034	0.00048	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—sarcoma	0.00034	0.00048	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—sarcoma	0.000339	0.000478	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000338	0.000476	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—sarcoma	0.000336	0.000474	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—sarcoma	0.000336	0.000474	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—sarcoma	0.000333	0.000469	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—sarcoma	0.000329	0.000464	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—sarcoma	0.000326	0.00046	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—sarcoma	0.000324	0.000457	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000321	0.000453	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—sarcoma	0.000321	0.000452	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—sarcoma	0.00032	0.000451	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—sarcoma	0.000319	0.00045	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—sarcoma	0.000319	0.000449	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—sarcoma	0.000318	0.000449	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—sarcoma	0.000317	0.000447	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—sarcoma	0.000316	0.000446	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—sarcoma	0.000315	0.000444	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—sarcoma	0.000314	0.000443	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—sarcoma	0.000313	0.000442	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—sarcoma	0.000311	0.000438	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—sarcoma	0.00031	0.000437	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—sarcoma	0.000306	0.000432	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—sarcoma	0.000304	0.000429	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—sarcoma	0.000304	0.000428	CcSEcCtD
Esomeprazole—Pain—Epirubicin—sarcoma	0.000301	0.000425	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—sarcoma	0.000301	0.000425	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000297	0.000419	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—sarcoma	0.000295	0.000416	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—sarcoma	0.000293	0.000413	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—sarcoma	0.000291	0.00041	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—sarcoma	0.00029	0.000409	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—sarcoma	0.00029	0.000409	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Epirubicin—sarcoma	0.000288	0.000406	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—sarcoma	0.000287	0.000405	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—sarcoma	0.000283	0.0004	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000282	0.000397	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—sarcoma	0.000281	0.000396	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—sarcoma	0.00028	0.000395	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—sarcoma	0.000279	0.000393	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—sarcoma	0.000279	0.000393	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—sarcoma	0.000279	0.000393	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—sarcoma	0.000279	0.000393	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—sarcoma	0.000269	0.000379	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—sarcoma	0.000267	0.000376	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—sarcoma	0.00026	0.000366	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—sarcoma	0.000259	0.000365	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—sarcoma	0.000258	0.000363	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—sarcoma	0.000258	0.000363	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—sarcoma	0.000253	0.000357	CcSEcCtD
Esomeprazole—Pruritus—Epirubicin—sarcoma	0.000249	0.000352	CcSEcCtD
Esomeprazole—Diarrhoea—Epirubicin—sarcoma	0.000241	0.00034	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—sarcoma	0.00024	0.000339	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—sarcoma	0.000234	0.00033	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—sarcoma	0.000233	0.000329	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—sarcoma	0.000231	0.000325	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—sarcoma	0.000224	0.000316	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—sarcoma	0.000223	0.000315	CcSEcCtD
Esomeprazole—Rash—Epirubicin—sarcoma	0.000222	0.000313	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—sarcoma	0.000222	0.000313	CcSEcCtD
Esomeprazole—Headache—Epirubicin—sarcoma	0.000221	0.000311	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—sarcoma	0.000216	0.000304	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—sarcoma	0.000209	0.000295	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—sarcoma	0.000207	0.000292	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—sarcoma	0.000206	0.00029	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—sarcoma	0.000205	0.00029	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—sarcoma	0.000204	0.000288	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—sarcoma	0.000194	0.000273	CcSEcCtD
